Dave Weiner

Item: Dave Weiner
Rating: 2.13
Author: StockAnalysis.com

Stock Analyst at Piper Sandler

(2.13)

# 2,899

Out of 5,127 analysts

Total ratings

50%

Success rate

15.79%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Dave Weiner

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	MYGN Myriad Genetics	Maintains: Overweight	$9 → $8.5	$6.56	+29.57%	4	Nov 11, 2025
	LULU lululemon athletica inc.	Upgrades: Buy	n/a	$212.17	-	5	Dec 14, 2017

Myriad Genetics

Nov 11, 2025

Maintains: Overweight

Price Target: $9 → $8.5

Current: $6.56

Upside: +29.57%

lululemon athletica inc.

Dec 14, 2017

Upgrades: Buy

Price Target: n/a

Current: $212.17

Upside: -